Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8924108 | IHJ Cardiovascular Case Reports (CVCR) | 2017 | 7 Pages |
Abstract
Bioprosthetic valve dysfunction leading to haemodynamically significant consequences is well recognised. Traditional treatment of choice has been conventional re-do surgical valve replacement. However, over the last decade, percutaneous solutions such as Valve-in-valve (VIV) implantations has emerged as a well-established option for such patients Dvir et al. (2014), V. Bapat et al. (2012) and Piazza et al. (2011). We report India's first tricuspid valve-in-valve implantation with a balloon expandable valve through a trans-jugular approach to treat dysfunctional tricuspid valve dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A.B. Gopalamurugan, R. Mohamed Abubacker, Prashant Vaijyanath,